These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34237345)

  • 1. An in-silico assessment of the dosimetric benefits of MR-guided radiotherapy for esophageal cancer patients.
    Boekhoff M; Defize I; Borggreve A; van Hillegersberg R; Kotte A; Lagendijk J; van Lier A; Ruurda J; Takahashi N; Mook S; Meijer G
    Radiother Oncol; 2021 Sep; 162():76-84. PubMed ID: 34237345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective study comparing MR-guided radiation therapy (MRgRT) setup strategies for prostate treatment: repositioning vs. replanning.
    Kim JI; Park JM; Choi CH; An HJ; Kim YJ; Kim JH
    Radiat Oncol; 2019 Aug; 14(1):139. PubMed ID: 31387593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetric Evaluation of Incorporating Patient Geometric Variations Into Adaptive Plan Optimization Through Probabilistic Treatment Planning in Head and Neck Cancers.
    Liu Q; Liang J; Zhou D; Krauss DJ; Chen PY; Yan D
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):985-997. PubMed ID: 29976511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daily dosimetric variation between image-guided volumetric modulated arc radiotherapy and MR-guided daily adaptive radiotherapy for prostate cancer stereotactic body radiotherapy.
    Nicosia L; Sicignano G; Rigo M; Figlia V; Cuccia F; De Simone A; Giaj-Levra N; Mazzola R; Naccarato S; Ricchetti F; Vitale C; Ruggieri R; Alongi F
    Acta Oncol; 2021 Feb; 60(2):215-221. PubMed ID: 32945701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical physics challenges in clinical MR-guided radiotherapy.
    Kurz C; Buizza G; Landry G; Kamp F; Rabe M; Paganelli C; Baroni G; Reiner M; Keall PJ; van den Berg CAT; Riboldi M
    Radiat Oncol; 2020 May; 15(1):93. PubMed ID: 32370788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of online adaptive MR-guided stereotactic body radiotherapy of liver cancers.
    Padgett KR; Simpson G; Asher D; Portelance L; Bossart E; Dogan N
    Phys Med; 2020 Sep; 77():54-63. PubMed ID: 32781388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR-guidance in clinical reality: current treatment challenges and future perspectives.
    Corradini S; Alongi F; Andratschke N; Belka C; Boldrini L; Cellini F; Debus J; Guckenberger M; Hörner-Rieber J; Lagerwaard FJ; Mazzola R; Palacios MA; Philippens MEP; Raaijmakers CPJ; Terhaard CHJ; Valentini V; Niyazi M
    Radiat Oncol; 2019 Jun; 14(1):92. PubMed ID: 31167658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of treatment plans for a high-field MRI-linac and a conventional linac for esophageal cancer.
    Nachbar M; Mönnich D; Kalwa P; Zips D; Thorwarth D; Gani C
    Strahlenther Onkol; 2019 Apr; 195(4):327-334. PubMed ID: 30361744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrafractional stability of MR-guided online adaptive SBRT for prostate cancer.
    Schaule J; Chamberlain M; Wilke L; Baumgartl M; Krayenbühl J; Zamburlini M; Mayinger M; Andratschke N; Tanadini-Lang S; Guckenberger M
    Radiat Oncol; 2021 Sep; 16(1):189. PubMed ID: 34565439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3-Dimensional target coverage assessment for MRI guided esophageal cancer radiotherapy.
    Boekhoff MR; Defize IL; Borggreve AS; Takahashi N; van Lier ALHMW; Ruurda JP; van Hillegersberg R; Lagendijk JJW; Mook S; Meijer GJ
    Radiother Oncol; 2020 Jun; 147():1-7. PubMed ID: 32234611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric comparison of library of plans and online MRI-guided radiotherapy of cervical cancer in the presence of intrafraction anatomical changes.
    Visser J; de Boer P; Crama KF; van Kesteren Z; Rasch CRN; Stalpers LJA; Bel A
    Radiat Oncol; 2019 Jul; 14(1):126. PubMed ID: 31300000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric Benefits of Midposition Compared With Internal Target Volume Strategy for Esophageal Cancer Radiation Therapy.
    Jin P; Machiels M; Crama KF; Visser J; van Wieringen N; Bel A; Hulshof MCCM; Alderliesten T
    Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):491-502. PubMed ID: 30253234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing local dose perturbations due to gas cavities in magnetic resonance-guided radiotherapy.
    Shortall J; Vasquez Osorio E; Chuter R; Green A; McWilliam A; Kirkby K; Mackay R; van Herk M
    Med Phys; 2020 Jun; 47(6):2484-2494. PubMed ID: 32144781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and longitudinal assessment of daily quality assurance for an MR-guided radiotherapy (MRgRT) linac.
    Mittauer KE; Dunkerley DAP; Yadav P; Bayouth JE
    J Appl Clin Med Phys; 2019 Nov; 20(11):27-36. PubMed ID: 31633882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gating has a negligible impact on dose delivered in MRI-guided online adaptive radiotherapy of prostate cancer.
    Wahlstedt I; Andratschke N; Behrens CP; Ehrbar S; Gabryś HS; Schüler HG; Guckenberger M; Smith AG; Tanadini-Lang S; Tascón-Vidarte JD; Vogelius IR; van Timmeren JE
    Radiother Oncol; 2022 May; 170():205-212. PubMed ID: 35351536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simulated daily plan adaptation for magnetic resonance-guided liver stereotactic body radiotherapy.
    Taylor E; Lukovic J; Velec M; Shessel A; Stanescu T; Dawson L; Létourneau D; Lindsay P
    Acta Oncol; 2021 Feb; 60(2):260-266. PubMed ID: 33170058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of treatment planning workflow and tumor coverage during daily adaptive magnetic resonance image guided radiation therapy (MR-IGRT) of pancreatic cancer.
    Olberg S; Green O; Cai B; Yang D; Rodriguez V; Zhang H; Kim JS; Parikh PJ; Mutic S; Park JC
    Radiat Oncol; 2018 Mar; 13(1):51. PubMed ID: 29573744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of MR-guided radiotherapy accumulated doses for central lung tumors with non-adaptive and online adaptive proton therapy.
    Rabe M; Palacios MA; van Sörnsen de Koste JR; Eze C; Hillbrand M; Belka C; Landry G; Senan S; Kurz C
    Med Phys; 2023 May; 50(5):2625-2636. PubMed ID: 36810708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric study.
    Welsh J; Gomez D; Palmer MB; Riley BA; Mayankkumar AV; Komaki R; Dong L; Zhu XR; Likhacheva A; Liao Z; Hofstetter WL; Ajani JA; Cox JD
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1336-42. PubMed ID: 21470796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of Adaptive MR-guided Stereotactic Body Radiotherapy (SBRT) of Lung Tumors.
    Padgett KR; Simpson GN; Llorente R; Samuels MA; Dogan N
    Cureus; 2018 Apr; 10(4):e2423. PubMed ID: 29872603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.